Ftse Mib
34.190,00
-0,31%
DAX
18.052,86
-0,44%
S&P 500
5.116,17
0,32%
NASDAQ Composite
15.983,08
0,35%
Bitcoin
61.460,03
-3,72%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Kiniksa Pharmaceuticals Ltd (KNSA) Kiniksa Pharmaceuticals Ltd (KNSA) Notizie

Kiniksa Pharmaceuticals Ltd

KNSA
18,55
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 13:00:11
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
23/4/202413:30GLOBEKiniksa Pharmaceuticals Reports First Quarter 2024 Financial..
16/4/202422:01GLOBEKiniksa Pharmaceuticals to Report First Quarter 2024..
02/4/202413:30GLOBEKiniksa Pharmaceuticals Announces Development Indication for..
05/3/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:29EDGAR2Form 144 - Report of proposed sale of securities
29/2/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202413:35EDGAR2Form 8-K - Current report
28/2/202413:30GLOBEKiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year..
27/2/202423:06EDGAR2Form 144 - Report of proposed sale of securities
21/2/202422:01GLOBEKiniksa Pharmaceuticals to Report Fourth Quarter and..
14/2/202422:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202421:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
04/1/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202413:37EDGAR2Form 8-K - Current report
04/1/202413:30GLOBEKiniksa Pharmaceuticals Provides Corporate Update
03/1/202422:55EDGAR2Form 144 - Report of proposed sale of securities
02/1/202422:01GLOBEKiniksa Pharmaceuticals to Present at 42nd Annual J.P...
11/12/202322:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202322:46EDGAR2Form 144 - Report of proposed sale of securities
02/11/202321:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202312:35EDGAR2Form 8-K - Current report
31/10/202312:30GLOBEKiniksa Pharmaceuticals Reports Third Quarter 2023 Financial..
24/10/202322:01GLOBEKiniksa Pharmaceuticals to Report Third Quarter 2023..
07/9/202301:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202301:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202301:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202301:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202323:26EDGAR2Form 144 - Report of proposed sale of securities
18/8/202322:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/8/202322:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01/8/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
27/7/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202323:14EDGAR2Form 144 - Report of proposed sale of securities
25/7/202313:40EDGAR2Form 8-K - Current report
25/7/202313:30GLOBEKiniksa Pharmaceuticals Reports Second Quarter 2023..
17/7/202314:00GLOBEKiniksa Pharmaceuticals to Report Second Quarter 2023..
06/6/202322:01GLOBEKiniksa Pharmaceuticals to Present at Goldman Sachs 44th..
02/5/202313:30GLOBEKiniksa Pharmaceuticals Reports First Quarter 2023 Financial..
01/5/202322:01GLOBEKiniksa Pharmaceuticals to Report First Quarter 2023..
Apertura: Min: Max:
Chiusura: 18,55

La tua Cronologia

NASDAQ
KNSA
Kiniksa Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network